Her primary areas of study are Internal medicine, Transplantation, Immunology, Hematopoietic stem cell transplantation and Surgery. Her Internal medicine research includes themes of Gastroenterology and Oncology. Her Transplantation study combines topics in areas such as Hematopoietic cell, Umbilical cord, Bone transplantation, Survival analysis and Bone marrow.
Her studies deal with areas such as Unrelated Donor and KIR Ligand as well as Immunology. Her Hematopoietic stem cell transplantation research is multidisciplinary, incorporating elements of Proportional hazards model, Hemophagocytic lymphohistiocytosis, Thrombotic microangiopathy and Gerontology. As part of one scientific family, Stella M. Davies deals mainly with the area of Surgery, narrowing it down to issues related to the Incidence, and often Myelogenous and ABO blood group system.
Her primary scientific interests are in Internal medicine, Transplantation, Immunology, Hematopoietic stem cell transplantation and Oncology. The concepts of her Internal medicine study are interwoven with issues in Gastroenterology and Surgery. Her Transplantation research is multidisciplinary, incorporating perspectives in Hematopoietic cell, Transplantation Conditioning, Stem cell, Disease and Pediatrics.
Her study in Immunology is interdisciplinary in nature, drawing from both Genotype, Fanconi anemia and Graft-versus-host disease. She focuses mostly in the field of Hematopoietic stem cell transplantation, narrowing it down to topics relating to Thrombotic microangiopathy and, in certain cases, Eculizumab and Complement system. Her Oncology research integrates issues from Cancer and Myeloid leukemia.
Her primary areas of investigation include Internal medicine, Gastroenterology, Immunology, Hematopoietic stem cell transplantation and Transplantation. Her work in Internal medicine is not limited to one particular discipline; it also encompasses Oncology. Her work deals with themes such as Interquartile range, Refractory, Renal function, Adverse effect and Graft-versus-host disease, which intersect with Gastroenterology.
Her research investigates the connection between Immunology and topics such as Hematopoietic cell that intersect with issues in Medical microbiology and MEDLINE. As part of her studies on Hematopoietic stem cell transplantation, Stella M. Davies often connects relevant areas like Urinary system. Her research integrates issues of Shwachman–Diamond syndrome, Chemotherapy and Cohort study in her study of Transplantation.
Her main research concerns Internal medicine, Hematopoietic stem cell transplantation, Gastroenterology, Transplantation and Immunology. Her study ties her expertise on Oncology together with the subject of Internal medicine. Her Hematopoietic stem cell transplantation research includes elements of Social support, Eculizumab, Cohort and Thrombotic microangiopathy.
She combines subjects such as Adverse effect, Pharmacodynamics, Phases of clinical research and Renal function with her study of Gastroenterology. Stella M. Davies interconnects Fanconi anemia, Chemotherapy, Confidence interval, Shwachman–Diamond syndrome and Asymptomatic in the investigation of issues within Transplantation. Her research investigates the connection between Immunology and topics such as Hemorrhagic cystitis that intersect with problems in BK virus and Viral pathogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Barthel ADL Index: a reliability study*
C. Collin;D. T. Wade;S. Davies;V. Horne.
International Disability Studies (1988)
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.
John E. Wagner;Juliet N. Barker;Todd E. DeFor;K. Scott Baker.
Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease
John E. Wagner;Joseph Rosenthal;Joseph Rosenthal;Robert Sweetman;Robert Sweetman;Xiao Ou Shu;Xiao Ou Shu.
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
Craig Kollman;Craig W. S. Howe;Claudio Anasetti;Joseph H. Antin.
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton.
Journal of Clinical Oncology (2009)
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
Sebastian Giebel;Franco W Locatelli;Teresa Lamparelli;Andrea Velardi.
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
Navneet S. Majhail;Navneet S. Majhail;J. Douglas Rizzo;Stephanie J. Lee;Mahmoud Aljurf.
Biology of Blood and Marrow Transplantation (2012)
The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research
Leslie L. Robison;Gregory T. Armstrong;John D. Boice;Eric J. Chow.
Journal of Clinical Oncology (2009)
Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen–matched unrelated donor bone marrow: results of a matched-pair analysis
Juliet N. Barker;Stella M. Davies;Todd DeFor;Norma K. C. Ramsay.
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
Stella M. Davies;Loredana Ruggieri;Todd DeFor;John E. Wagner.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: